Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005840 | ribosome | 5 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006412 | translation | 4 | 1 |
GO:0006518 | peptide metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 1 |
GO:0043043 | peptide biosynthetic process | 5 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0043604 | amide biosynthetic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003735 | structural constituent of ribosome | 2 | 1 |
GO:0005198 | structural molecule activity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 239 | 243 | PF00656 | 0.503 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.514 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.433 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.614 |
CLV_NRD_NRD_1 | 253 | 255 | PF00675 | 0.549 |
CLV_NRD_NRD_1 | 256 | 258 | PF00675 | 0.543 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.735 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.407 |
CLV_PCSK_PC1ET2_1 | 246 | 248 | PF00082 | 0.735 |
CLV_PCSK_PC1ET2_1 | 53 | 55 | PF00082 | 0.407 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.561 |
CLV_PCSK_SKI1_1 | 257 | 261 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.444 |
DEG_APCC_KENBOX_2 | 64 | 68 | PF00400 | 0.469 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.539 |
DEG_SPOP_SBC_1 | 235 | 239 | PF00917 | 0.572 |
DOC_CKS1_1 | 179 | 184 | PF01111 | 0.458 |
DOC_CYCLIN_RxL_1 | 180 | 193 | PF00134 | 0.573 |
DOC_CYCLIN_RxL_1 | 93 | 104 | PF00134 | 0.472 |
DOC_CYCLIN_yCln2_LP_2 | 8 | 14 | PF00134 | 0.496 |
DOC_MAPK_gen_1 | 2 | 9 | PF00069 | 0.596 |
DOC_MAPK_gen_1 | 252 | 261 | PF00069 | 0.548 |
DOC_MAPK_gen_1 | 95 | 102 | PF00069 | 0.453 |
DOC_MAPK_MEF2A_6 | 17 | 24 | PF00069 | 0.481 |
DOC_MAPK_MEF2A_6 | 95 | 102 | PF00069 | 0.469 |
DOC_PP1_RVXF_1 | 124 | 130 | PF00149 | 0.541 |
DOC_PP2B_LxvP_1 | 165 | 168 | PF13499 | 0.434 |
DOC_PP2B_LxvP_1 | 8 | 11 | PF13499 | 0.487 |
DOC_PP4_MxPP_1 | 24 | 27 | PF00568 | 0.464 |
DOC_USP7_MATH_1 | 235 | 239 | PF00917 | 0.619 |
DOC_USP7_UBL2_3 | 159 | 163 | PF12436 | 0.223 |
DOC_USP7_UBL2_3 | 187 | 191 | PF12436 | 0.515 |
DOC_USP7_UBL2_3 | 248 | 252 | PF12436 | 0.574 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.461 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.401 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 85 | 90 | PF00397 | 0.405 |
LIG_14-3-3_CanoR_1 | 2 | 9 | PF00244 | 0.568 |
LIG_14-3-3_CanoR_1 | 54 | 64 | PF00244 | 0.447 |
LIG_14-3-3_CanoR_1 | 84 | 88 | PF00244 | 0.566 |
LIG_APCC_ABBA_1 | 87 | 92 | PF00400 | 0.463 |
LIG_CSL_BTD_1 | 11 | 14 | PF09270 | 0.456 |
LIG_eIF4E_1 | 201 | 207 | PF01652 | 0.419 |
LIG_FHA_1 | 108 | 114 | PF00498 | 0.494 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.315 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.500 |
LIG_KLC1_Yacidic_2 | 135 | 140 | PF13176 | 0.358 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 204 | 210 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 222 | 228 | PF02991 | 0.449 |
LIG_SH2_CRK | 162 | 166 | PF00017 | 0.411 |
LIG_SH2_CRK | 185 | 189 | PF00017 | 0.489 |
LIG_SH2_NCK_1 | 134 | 138 | PF00017 | 0.385 |
LIG_SH2_STAP1 | 134 | 138 | PF00017 | 0.383 |
LIG_SH2_STAP1 | 153 | 157 | PF00017 | 0.192 |
LIG_SH2_STAP1 | 201 | 205 | PF00017 | 0.501 |
LIG_SH2_STAP1 | 42 | 46 | PF00017 | 0.394 |
LIG_SH2_STAP1 | 60 | 64 | PF00017 | 0.424 |
LIG_SH2_STAP1 | 81 | 85 | PF00017 | 0.423 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.438 |
LIG_SH3_2 | 72 | 77 | PF14604 | 0.560 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.449 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.429 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.575 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.461 |
LIG_SUMO_SIM_anti_2 | 226 | 234 | PF11976 | 0.438 |
LIG_SUMO_SIM_par_1 | 98 | 104 | PF11976 | 0.446 |
LIG_TRAF2_1 | 144 | 147 | PF00917 | 0.475 |
LIG_WW_3 | 14 | 18 | PF00397 | 0.458 |
MOD_CDC14_SPxK_1 | 74 | 77 | PF00782 | 0.556 |
MOD_CDK_SPxK_1 | 71 | 77 | PF00069 | 0.565 |
MOD_CDK_SPxxK_3 | 46 | 53 | PF00069 | 0.421 |
MOD_CK1_1 | 234 | 240 | PF00069 | 0.628 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.633 |
MOD_CK2_1 | 170 | 176 | PF00069 | 0.470 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.469 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.605 |
MOD_GlcNHglycan | 242 | 246 | PF01048 | 0.639 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.634 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.530 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.453 |
MOD_N-GLC_1 | 170 | 175 | PF02516 | 0.545 |
MOD_N-GLC_1 | 66 | 71 | PF02516 | 0.456 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.529 |
MOD_NEK2_1 | 231 | 236 | PF00069 | 0.603 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.411 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.556 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.526 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.552 |
MOD_Plk_1 | 170 | 176 | PF00069 | 0.551 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.456 |
MOD_Plk_2-3 | 190 | 196 | PF00069 | 0.502 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.280 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.302 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.460 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.405 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.565 |
MOD_ProDKin_1 | 85 | 91 | PF00069 | 0.399 |
TRG_DiLeu_BaEn_1 | 160 | 165 | PF01217 | 0.328 |
TRG_DiLeu_BaLyEn_6 | 111 | 116 | PF01217 | 0.245 |
TRG_DiLeu_BaLyEn_6 | 95 | 100 | PF01217 | 0.456 |
TRG_ENDOCYTIC_2 | 134 | 137 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.390 |
TRG_ENDOCYTIC_2 | 185 | 188 | PF00928 | 0.418 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.536 |
TRG_ER_diLys_1 | 258 | 262 | PF00400 | 0.552 |
TRG_NLS_Bipartite_1 | 246 | 261 | PF00514 | 0.567 |
TRG_NLS_MonoExtC_3 | 245 | 250 | PF00514 | 0.635 |
TRG_NLS_MonoExtC_3 | 253 | 258 | PF00514 | 0.508 |
TRG_NLS_MonoExtN_4 | 252 | 258 | PF00514 | 0.548 |
TRG_Pf-PMV_PEXEL_1 | 186 | 190 | PF00026 | 0.561 |
TRG_Pf-PMV_PEXEL_1 | 97 | 101 | PF00026 | 0.440 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2A6 | Leptomonas seymouri | 83% | 100% |
A0A0S4KHU8 | Bodo saltans | 63% | 100% |
A0A1X0NP98 | Trypanosomatidae | 70% | 100% |
A0A3R7M4H0 | Trypanosoma rangeli | 71% | 100% |
A0A3S5H637 | Leishmania donovani | 90% | 100% |
A4HTH5 | Leishmania infantum | 90% | 100% |
C9ZPL2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 75% | 100% |
E9AMA3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QIE5 | Leishmania major | 91% | 100% |
V5BCI9 | Trypanosoma cruzi | 73% | 100% |